Zaytseva2: sample sizes

Number of animals tested for each measure in this project, by strain and sex.       Cells with N < 5 are colored pink.


More info about these strains
Zaytseva2 measure Sex BEW_BG CAMERON_GA CC008/Geni CC010/Geni CC012/Geni CC013/Geni CC016/Geni CC020/Geni CC022/Geni CC023/Geni CC024/Geni CC025/Geni CC026/Geni CC027/Geni CC030/Geni CC032/Geni CC033/Geni CC042/Geni CC043/Geni CC045/Geni CC056/Geni CC061/Geni CIS2_AD CIV2_FE DET3_GA DONNELL_HA FIV_AC FUF_HE GALASUPREME_CE GAV_FG GET_GC GIT_GC HAX2_EF HAZ_FE HIP_GA HOE_GC JAFFA_CE JEUNE_CA JUD_EF KAV_AF LAK_DA LAM_DC LAX_FC LEL_FH LEM2_AF LEM_AF LIP_BG LOM_BG LON_GH LOT_FC LUF_AD LUG_EH LUV_DG LUZ_FH MAK_DG MOP_EF PAT_CD PEF2_EC PEF_EC PER2_AD POH2_DC POH_DC RAE2_CD REV_HG ROGAN_CF SEH_AH SOLDIER_BG SOZ_AC STUCKY_HF TUY_BA VIT_ED VOY_GH VUX2_HF WOT2_DC WOT2_DF XAB8_DA XAB_DA XAD7_BG XAD8_BG XAN_DG XAO_AF XAP_AE XAS4_AF XAS_AF XAV_AH XEB2_AF XEB_AF XED2_AD XEH2_HD XEQ_EH XXEN3_DC XXXEC_GF YOX_DE ZIE2_HA ZOE_HA
mIgG1_B   IgG1 with bisected N-acetylglucosamine N-glycan structures (relative abundance)   110032 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_G   IgG1 with galactosylated N-glycan structures (relative abundance)   110033 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_G0   IgG1 with agalactosylated N-glycan structures (relative abundance)   110034 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_G1   IgG1 with monogalactosylated N-glycan structures (relative abundance)   110035 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_G2   IgG1 with digalactosylated N-glycan structures (relative abundance)   110036 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_S   IgG1 with sialylated N-glycan structures (relative abundance)   110037 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_S1   IgG1 with monosialylated N-glycan structures (relative abundance)   110038 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_S2   IgG1 with disialylated N-glycan structures (relative abundance)   110039 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG1_aGal   IgG1 with alpha1,3-linked galactose residue N-glycan structures (relative abundance)   110040 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 2 1 1 2 1 3 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_B   IgG2 with bisected N-acetylglucosamine N-glycan structures (relative abundance)   110041 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_G   IgG2 with galactosylated N-glycan structures (relative abundance)   110042 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_G0   IgG2 with agalactosylated N-glycan structures (relative abundance)   110043 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_G1   IgG2 with monogalactosylated N-glycan structures (relative abundance)   110044 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_G2   IgG2 with digalactosylated N-glycan structures (relative abundance)   110045 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_S   IgG2 with sialylated N-glycan structures (relative abundance)   110046 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_S1   IgG2 with monosialylated N-glycan structures (relative abundance)   110047 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_S2   IgG2 with disialylated N-glycan structures (relative abundance)   110048 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG2_aGal   IgG2 with alpha1,3-linked galactose residue N-glycan structures (relative abundance)   110049 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 3 1 1 2 1 1 2 1 4 2 1 3 1 2 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 3 2 1 3 1 3 3 3 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 1 1 2 2 2 2 1 2 2 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_B   IgG3 with bisected N-acetylglucosamine N-glycan structures (relative abundance)   110050 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_G   IgG3 with galactosylated N-glycan structures (relative abundance)   110051 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_G0   IgG3 with agalactosylated N-glycan structures (relative abundance)   110052 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_G1   IgG3 with monogalactosylated N-glycan structures (relative abundance)   110053 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_G2   IgG3 with digalactosylated N-glycan structures (relative abundance)   110054 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_S   IgG3 with sialylated N-glycan structures (relative abundance)   110055 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_S1   IgG3 with monosialylated N-glycan structures (relative abundance)   110056 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_S2   IgG3 with disialylated N-glycan structures (relative abundance)   110057 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1
mIgG3_aGal   IgG3 with alpha1,3-linked galactose residue N-glycan structures (relative abundance)   110058 (F) 1 1 3 2 3 3 2 3 1 2 2 2 1 2 4 2 3 3 1 1 2 3 1 3 3 2 3 3 3 1 1 2 3 3 1 1 1 2 1 1 2 1 2 2 1 3 1 1 2 1 1 1 2 1 2 3 4 1 1 2 2 3 2 2 4 2 2 1 3 1 3 3 2 3 3 3 2 2 1 1 3 1 1 1 2 2 2 1 2
(M) 1 2 2 2 3 2 2 1 2 2 4 1 2 1 2 1 1 2 1 3 1 1 1 4 2 2 1 1 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 2 1 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 1 3 3 3 2 2 4 2 1 1 3 2 1 1 2 2 1 2 3 1